Kish, E. K., Zereshkian, A., Maganti, M., Veit-Haibach, P., Finelli, A., Fleshner, N. E., Trachtenberg, J., Perlis, N., Berlin, A., Bayley, A., Catton, C., Chung, P., Warde, P., Ali, S., Kumar, V., Al-Ezzi, E. M., Fallah-Rad, N., Sridhar, S. S., Jiang, D. M. (2026). Real-world utilization and timing of initiation of bone-targeting agents (BTAs) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223: Results from Princess Margaret Cancer Centre (PM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.68